Robert J. Rosenthalofficer

Biography

 Bob Rosenthal has more than 30 years’ experience fostering product innovation and building value for customers, shareholders, and employees in scientific and technical companies. He is currently CEO of Hudson, New York-based Taconic Biosciences, a leading supplier of research models for pharmaceutical and biotech organizations. Previously, Bob served as chairman and CEO at Intelligent Medical Implants (IMI), a developer of technologies designed to restore vision to individuals blinded by diseases such as retinitis pigmentosa. Prior to IMI, he was president and CEO of Magellan Biosciences, where he helped build the company from a start-up to more than $100 million in revenues. Previously, he was president and CEO of Boston Life Sciences, an R&D development-phase biopharmaceutical company, president of PerkinElmer’s Instruments division, where he managed the acquisition and integration of the Analytical Instruments group from PE Corporation, and president and CEO of Thermo Optek, (now part of Thermo Fisher Scientific). He began his management career at Wisconsin-based Nicolet Instrument Corporation, ultimately becoming its president after Thermo Instrument Systems acquired the company. In addition to serving on Galvanic’s board, he is also a board member of Safeguard Scientifics, Inc. He holds bachelor’s, master’s, and doctorate degrees in chemistry from the University of Maryland, The State University of New York, and Emory University respectively, as well as an AEA Executive MBA from Stanford University.

Research Interest

 science